EII Capital Management’s COPT Defense Properties CDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-15,059
Closed -$406K 34
2021
Q3
$406K Sell
15,059
-910
-6% -$25.9K 0.19% 115
2021
Q2
$447K Buy
15,969
+1,540
+11% +$43K 0.21% 114
2021
Q1
$380K Sell
14,429
-867
-6% -$22.9K 0.2% 115
2020
Q4
$399K Sell
15,296
-3,296
-18% -$83.1K 0.22% 108
2020
Q3
$441K Buy
18,592
+3,518
+23% +$87.7K 0.28% 92
2020
Q2
$382K Hold
15,074
0.25% 95
2020
Q1
$334K Hold
15,074
0.22% 109
2019
Q4
$443K Hold
15,074
0.12% 117
2019
Q3
$449K Buy
15,074
+7,884
+110% +$223K 0.12% 120
2019
Q2
$190K Buy
7,190
+208
+3% +$5.8K 0.1% 151
2019
Q1
$191K Sell
6,982
-3,014
-30% -$76.1K 0.11% 154
2018
Q4
$210K Sell
9,996
-2,601
-21% -$66.2K 0.12% 149
2018
Q3
$327K Sell
12,597
-1,143
-8% -$34.2K 0.18% 124
2018
Q2
$398K Hold
13,740
0.21% 114
2018
Q1
$355K Sell
13,740
-5,675
-29% -$150K 0.21% 115
2017
Q4
$567K Sell
19,415
-4,508
-19% -$141K 0.24% 124
2017
Q3
$785K Buy
+23,923
New +$799K 0.29% 118

Other funds holding CDP

EII Capital Management's CDP Position: Q4 2021 in Review

EII Capital Management sold out of COPT Defense Properties (CDP) in Q4 2021, closing a stake of 15,059 shares — an estimated $406K sold.

EII Capital Management first reported a position in CDP in Q3 2017 and held it in 17 quarters. The position peaked at $785K in Q3 2017. 256 funds tracked by Wall St. Rank hold CDP as of Q4 2021.

  • EII Capital Management reported no remaining COPT Defense Properties position as of Q4 2021 after selling out during the quarter.
  • EII Capital Management sold 15,059 COPT Defense Properties shares in Q4 2021, an estimated $406K.
  • EII Capital Management first reported a position in COPT Defense Properties in Q3 2017 and held it in 17 quarters.
  • EII Capital Management's COPT Defense Properties position peaked at $785K in Q3 2017.
  • 256 funds tracked by Wall St. Rank held COPT Defense Properties as of Q4 2021.

Based on EII Capital Management's 13F filing for Q4 2021, filed 21 Jan 2022.